Attached files

file filename
EX-23.1 - EX-23.1 - Wave Life Sciences Ltd.wve-ex231_6.htm
10-K - 10-K - Wave Life Sciences Ltd.wve-10k_20201231.htm
EX-31.2 - EX-31.2 - Wave Life Sciences Ltd.wve-ex312_10.htm
EX-31.1 - EX-31.1 - Wave Life Sciences Ltd.wve-ex311_9.htm
EX-10.15 - EX-10.15 - Wave Life Sciences Ltd.wve-ex1015_410.htm
EX-4.2 - EX-4.2 - Wave Life Sciences Ltd.wve-ex42_411.htm
EX-10.5.2 - EX-10.5.2 - Wave Life Sciences Ltd.wve-ex1052_412.htm

Exhibit 32

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Wave Life Sciences Ltd., a Singapore corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report for the year ended December 31, 2020 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 4, 2021 

/s/ Paul B. Bolno, M.D.

Paul B. Bolno, M.D.

President and Chief Executive Officer

Principal Executive Officer

 

Dated: March 4, 2021

/s/ Kyle Moran

Kyle Moran

Chief Financial Officer

Principal Financial Officer